ALIA CX300

Overview

Conventional takeoff and landing electric aircraft in BETA's ALIA family, designed for cargo, medical, and regional passenger missions using existing airport infrastructure. BETA's stepwise commercialization plan puts the CTOL aircraft into service first before the VTOL variant.

BETA is commercializing the CTOL aircraft first while continuing FAA type certification across the ALIA family. On July 10, 2026 the CX300 flew the first operational missions of the U.S. DOT/FAA eIPP, carrying United Therapeutics' manufactured organs across a Virginia–Maryland corridor.

Key Specs